Type: Public
On the web: http://www.lectec.com

It's all a skin game at LecTec. The company formerly made (and now licenses) topical patches that deliver over-the-counter drugs through the skin. Its products include cooling, anti-itch, and pain relief patches, as well as acne treatments and wart removers. LecTec ceased manufacturing a few years ago, and is now licensing its intellectual property. The company currently licenses its technology to Novartis for that company's Triaminic Vapor Patch, a children's cough suppressant; the patch was recalled in 2006 after children who ate it got sick. LecTec is pursuing additional licensing agreements with Novartis, as well as seeking other licensing partners.

Key numbers for fiscal year ending December, 2007:
Sales: $0.1M
One year growth: (23.1%)
Net income: ($0.8)M

Officers:
Chairman, CEO, and CFO: Drug Delivery Systems
EVP and General Manager, Drummond American Corporation: R. Steve Broome
SVP and CIO: Hardware & Fastener Manufacturing

Competitors:
Chattem
Johnson & Johnson
ROHTO